South & Central America Lateral Flow Assay Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South & Central America Lateral Flow Assay Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South & Central America Lateral Flow Assay Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Use of Home-Based Assay Kits

5.2 Market Opportunities

5.2.1 Evolving Applications of Lateral Flow Assays

5.3 Future Trends

5.3.1 Smartphone Usage and Al Integration in Lateral Flow Immunoassay

5.4 Impact of Drivers and Restraints

6. South & Central America Lateral Flow Assay Market Regional Analysis

6.1 South & Central America Lateral Flow Assay Market Overview

6.2 South & Central America Lateral Flow Assay Market Revenue 2020-2030 (US$ Million)

6.3 South & Central America Lateral Flow Assay Market Forecast Analysis

7. South & Central America Lateral Flow Assay Market Analysis – by Product Type

7.1 Kits & Reagents and Lateral Flow Readers

7.1.1 Overview
7.1.2 Kits & Reagents and Lateral Flow Readers: South & Central America Lateral Flow Assay Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Lateral Flow Assay Market Analysis – by Technique

8.1 Sandwich Assay

8.1.1 Overview
8.1.2 Sandwich Assay: South & Central America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Competitive Assays

8.2.1 Overview
8.2.2 Competitive Assays: South & Central America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Multiplex Detection Assay

8.3.1 Overview
8.3.2 Multiplex Detection Assay: South & Central America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Lateral Flow Assay Market Analysis – by Test Type

9.1 Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay

9.1.1 Overview
9.1.2 Multiplex Detection Assay: South & Central America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Lateral Flow Assay Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South & Central America Lateral Flow Assay Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 South & Central America Lateral Flow Assay Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South & Central America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Brazil: South & Central America Lateral Flow Assay Market Breakdown, by Product Type
10.1.1.1.2 Brazil: South & Central America Lateral Flow Assay Market Breakdown, by Technique
10.1.1.1.3 Brazil: South & Central America Lateral Flow Assay Market Breakdown, by Test Type

10.1.1.2 Argentina: South & Central America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Argentina: South & Central America Lateral Flow Assay Market Breakdown, by Product Type
10.1.1.2.2 Argentina: South & Central America Lateral Flow Assay Market Breakdown, by Technique
10.1.1.2.3 Argentina: South & Central America Lateral Flow Assay Market Breakdown, by Test Type

10.1.1.3 Rest of South and Central America : South & Central America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South & Central America Lateral Flow Assay Market Breakdown, by Product Type
10.1.1.3.2 Rest of South and Central America : South & Central America Lateral Flow Assay Market Breakdown, by Technique
10.1.1.3.3 Rest of South and Central America : South & Central America Lateral Flow Assay Market Breakdown, by Test Type

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South & Central America Lateral Flow Assay Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Becton Dickinson and Co

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 PerkinElmer Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Hologic Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 QIAGEN NV

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 bioMerieux SA

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 QuidelOrtho Corp

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Abbott Laboratories

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Merck KGaA

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Bio-Rad Laboratories Inc

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 Thermo Fisher Scientific Inc

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights